Home » Newsletters » BioWorld

BioWorld

April 15, 1993

View Archived Issues

DNAP EXPANDS TEST MARKETS FOR ITS VINESWEET TOMATO

EDITEK'S ONE-STEP ASSAY RECEIVES PATENT

IMCLONE GETS LICENSE TO EGFR MABS

SANDOZ SELLS HUMAN MAbs TO PDL FOR $5 MILLION

SANDOZ AND SYSTEMIX TEAM UP FOR AIDS GENE THERAPY

CALGENE WILL LABEL ITS ANTISENSE TOMATO

GREENWICH FILES PLA

LIFECELL GETS SBIR GRANT

CELLTECH TO BUILD MANUFACTURING FACILITY IN N.H.

PPTI GETS PATENT FOR BETASILK

SANDOZ LICENSES BTG'S AMINOPEPTIDASE

ARMY TRANSFERS AIDS TRIAL FUNDS TO DHHS

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
ADEL wins $1.04B Sanofi deal for tau-targeting Alzheimer’s drug
BioWorld
ADEL Inc. closed a year-end licensing deal worth up to $1.04 billion with Sanofi SA for ADEL-Y01, a specific tau-targeting Alzheimer’s disease drug candidate in a...